Scandinavian Journal of Pain
Volume 3, Issue 1 , Pages 1-4 , January 2012

Keeping an open mind: Achieving balance between too liberal and too restrictive prescription of opioids for chronic non-cancer pain: Using a two-edged sword

  • Harald Breivik

      Affiliations

    • University of Oslo and Oslo University Hospital, Department of Pain Management and Pain Research, Oslo, Norway
    • Corresponding Author InformationCorresponding author.
    • ,
  • Torsten Gordh

      Affiliations

    • University of Uppsala and Uppsala University Hospital, Multidisciplinary Pain Centre, 751 85 Uppsala, Sweden
    • ,
  • Stephen Butler

      Affiliations

    • University of Uppsala and Uppsala University Hospital, Multidisciplinary Pain Centre, 751 85 Uppsala, Sweden

References 

  1. Watson CPN. Chronic non-cancer pain and long-term efficacy and safety of opioids: some blind men and an elephant. Scand J Pain. 2012;3:5–13
  2. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007;11:490–518
  3. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–255
  4. Fields HL. Should we be reluctant to prescribe opioids for chronic non-malignant pain. Pain. 2007;129:233–234
  5. Godlee F. On keeping an open mind. BMJ. 2011;343:d7125
  6. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;Issue 1. Art. No.: CD006605, CD006605.pub2
  7. Breivik H, Ljosaa TM, Stengaard-Pedersen K, Persson J, Aro H, Villumsen J, et al. A 6-months, randomized, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids. Scand J Pain. 2010;1:122–141
  8. British Pain Society . Opioids for persistent pain: good practice. London: BPS; 2010;Available from: http://www.britishpainsociety.org/pub_professional.htm
  9. Kahan M, Mailis-Gagnon A. Tunks E.Canadian guideline for safe and effective use of opioids for chronic non-cancer pain: implications for pain physicians. Pain Res Manag. 2011;16:157–158
  10. Dillie KS, Fleming MF, Mundt MP, French MT. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108–117
  11. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380
  12. Portenoy RK. Appropriate use of opioids for persistent non-cancer pain. Lancet. 2004;364:739–740
  13. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011;152:1256–1262
  14. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321
  15. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ. 2011;343:
  16. Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC. Increasing use of opioids from 2004 to 2007 – pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain. 2010;14:289–294
  17. Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010;149:345–353
  18. Katz MH. Long-term opioid treatment of chronic nonmalignant pain: a believer loses his faith. Arch Intern Med. 2010;170:1422.4
  19. Balantyne JC. Pain medicine: repairing a fractured dream. Anesthesiology. 2011;114
  20. Gramstad L, Haugtomt H, Breivik H. Use of opioids in chronic non-cancer pain – current status in Norway. In:  Kalso E,  Paakkari P,  Stenberg I editor. Opioids in chronic non-cancer pain. Situation and guidelines in Nordic countries. Helsinki: National Agency for Medicines; 1999;p. 31–37
  21. Fredheim OM, Borchgrevink PC, Breivik H. Nye begrep knyttet til opioidbehandling: Problematisk opioid bruk, addiksjon, iatrogent påført feilbruk (New definitions of problematic opioid use, addiction, iatrogenic wrong usage of opioids for chronic pain), Tidsskr Nor Laegeforen. 2008;128:2626
  22. Kalso E, Hearn L, Williams AC. Reducing the risk of opioid misuse in persistent pain: commentary on Jamison et al. Pain. 2010;150:375–376
  23. Rhodin A, Grönbladh L, Nilsson LH, Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence – a long-term follow-up. Eur J Pain. 2006;10:271–278
  24. Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD, et al. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150:390–400
  25. Ballantyne JC. Regulation of opioid prescribing: over-regulation compromises doctors’ ability to treat patients. BMJ. 2007;334:811–812
  26. Balantyne JC. US opioid risk management initiatives. Pain: clinical updates. vol. 17. IASP Press; 2009;pp 1–5
  27. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172–179
  28. Watson CPN, Watt-Watson JH, Chipman MA. The long-term efficacy and safety of opioids: a survey of 84 selected patients with intractable chronic non-cancer pain. Pain Res Manage. 2010;15:213–218

PII: S1877-8860(11)00151-0

doi: 10.1016/j.sjpain.2011.11.012

Scandinavian Journal of Pain
Volume 3, Issue 1 , Pages 1-4 , January 2012

Article Tools